Vivani Medical VANI Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive) at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vivani Medical's total cash, cash equivalents, and restricted cash (inclusive).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vivani Medical's total cash, cash equivalents, and restricted cash (inclusive)?
- Vivani Medical (VANI) reported total cash, cash equivalents, and restricted cash (inclusive) of $21.09M in Q1 2026.
- How has Vivani Medical's total cash, cash equivalents, and restricted cash (inclusive) changed year-over-year?
- Vivani Medical's total cash, cash equivalents, and restricted cash (inclusive) increased by 47.0% year-over-year, from $14.35M to $21.09M.
- What is the long-term trend for Vivani Medical's total cash, cash equivalents, and restricted cash (inclusive)?
- Over 5 years (2020 to 2025), Vivani Medical's total cash, cash equivalents, and restricted cash (inclusive) has grown at a 53.2% compound annual growth rate (CAGR), from $2.08M to $17.57M.
- What does total cash, cash equivalents, and restricted cash (inclusive) mean?
- This represents the total liquidity available to the company, including cash on hand, highly liquid short-term investments, and restricted cash balances. It is the primary metric for assessing a company's ability to fund ongoing research, development, and operational activities without immediate external financing. For preclinical firms, this is the most critical indicator of runway and financial stability.